The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 67 articles
DAPT guided by platelet function tests or genotyping after PCI: pros and cons
September 18, 2023 | 10.4244/EIJ-E-23-00022
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI
Spirito A,
Itchhaporia D,
Sartori S,
Camenzind E,
Chieffo A,
Dangas G,
Galatius S,
Jeger RV,
Kandzari D,
Kastrati A,
Kim H,
Kimura T,
Leon MB,
Mehta LS,
Mikhail G,
Morice M,
Nicolas J,
Pileggi B,
Serruys P,
Smits PC,
Steg PG,
Stone G,
Valgimigli M,
Vogel B,
von Birgelen C,
Weisz G,
Wijns W,
Windecker S,
Mehran R
August 21, 2023 | 10.4244/EIJ-D-23-00086
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
Guimarães PO,
Franken M,
Tavares CAM,
Silveira FS,
Antunes MO,
Bergo RR,
Joaquim RM,
Hirai JC,
Andrade PB,
Pitta FG,
Mariani Jr. J,
Nascimento BR,
de Paula JE,
Silveira MS,
Costa TA,
Dall’Orto FT,
Serpa RG,
Sampaio FB,
Ohe LN,
Mangione FM,
Furtado RH,
Sarmento-Leite R,
Monfardini F,
Assis SR,
Nicolau JC,
Sposito AC,
Lopes RD,
Onuma Y,
Valgimigli M,
Angiolillo D,
Serruys P,
Berwanger O,
Bacal F,
Lemos PA
July 17, 2023 | 10.4244/EIJ-D-23-00125
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry
Gargiulo G,
Marenna A,
Sperandeo L,
Manzi L,
Avvedimento M,
Simonetti F,
Canonico M,
Paolillo R,
Spinelli A,
Borgia F,
Diserafino L,
Franzone A,
Stabile E,
Piccolo R,
Cirillo P,
Valgimigli M,
Esposito G
March 20, 2023 | 10.4244/EIJ-D-22-00594
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska JJ,
Piek J,
Garg S,
Hamm C,
Steg G,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
August 5, 2022 | 10.4244/EIJ-D-21-00870
Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!
July 22, 2022 | 10.4244/EIJ-E-22-00004
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score
Gragnano F,
Jolly S,
Mehta SR,
Branca M,
van Klaveren D,
Frigoli E,
Gargiulo G,
Leonardi S,
Vranckx P,
Di Maio D,
Monda E,
Fimiani L,
Fioretti V,
Chianese S,
Andò G,
Esposito G,
Sangiorgi G,
Biondi-Zoccai G,
Heg D,
Calabrò P,
Windecker S,
Romagnoli E,
Valgimigli M
December 17, 2021 | 10.4244/EIJ-D-21-00441
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis
September 20, 2021 | 10.4244/EIJ-D-20-01197
Subcutaneous RUC-4 for acute myocardial infarction: a new treatment on the horizon for pre-hospital care?
August 6, 2021 | 10.4244/EIJV17I5A63
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions
Zimarino M,
Angiolillo D,
Dangas G,
Capodanno D,
Barbato E,
Hahn J,
Giustino G,
Watanabe H,
Costa F,
Cuisset T,
Rossini R,
Sibbing D,
Burzotta F,
Louvard Y,
Shehab A,
Renda G,
Kimura T,
Gwon H,
Chen S,
Costa R,
Koo B,
Storey R,
Valgimigli M,
Mehran R,
Stankovic G
May 16, 2021 | 10.4244/EIJ-D-20-00885
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter R,
Hamm C,
Steg G,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
Ueki Y,
Bär S,
Losdat S,
Otsuka T,
Zanchin C,
Zanchin T,
Gragnano F,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Hunziker L,
Stortecky S,
Pilgrim T,
Heg D,
Valgimigli M,
Windecker S,
Räber L
August 28, 2020 | 10.4244/EIJ-D-20-00052
The SYNTAX score on its way out or … towards artificial intelligence: part I
Serruys P,
Chichareon P,
Modolo R,
Leaman D,
Reiber J,
Emanuelsson H,
Di Mario C,
Pijls N,
Morel M,
Valgimigli M,
Farooq V,
van Klaveren D,
Capodanno D,
Andreini D,
Bourantas C,
Davies J,
Banning A,
Escaned J,
Piek J,
Echavarria-Pinto M,
Taylor C,
Thomsen B,
Collet C,
Pompilio G,
Bartorelli AL,
Glocker B,
Dressler O,
Stone G,
Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543A
The SYNTAX score on its way out or … towards artificial intelligence: part II
Serruys P,
Chichareon P,
Modolo R,
Leaman D,
Reiber J,
Emanuelsson H,
Di Mario C,
Pijls N,
Morel M,
Valgimigli M,
Farooq V,
van Klaveren D,
Capodanno D,
Andreini D,
Bourantas C,
Davies J,
Banning A,
Escaned J,
Piek J,
Echavarria-Pinto M,
Taylor C,
Thomsen B,
Collet C,
Pompilio G,
Bartorelli AL,
Glocker B,
Dressler O,
Stone G,
Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543B
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial
Tomaniak M,
Chichareon P,
Modolo R,
Takahashi K,
Chang C,
Kogame N,
Spitzer E,
Buszman P,
van Geuns R,
Valkov V,
Steinwender C,
Geisler T,
Prokopczuk J,
Sabaté M,
Zmudka K,
Rademaker-Havinga T,
Tijssen J,
Jüni P,
Hamm C,
Steg G,
Onuma Y,
Vranckx P,
Valgimigli M,
Windecker S,
Baber U,
Anderson R,
Dominici M,
Serruys P
April 3, 2020 | 10.4244/EIJ-D-19-00699
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber CK,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg G,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023